Factor VIII Deficient – Depleted Plasma is manufactured from normal citrated human plasma that has been depleted of Factor VIII by selective affinity immuno-adsorption using antibodies directed towards FVIII.
Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1ml vials to litre quantities. Our Factor VIII deficient – depleted plasma can be used for further manufacturing or research use only applications.
Product Code:FVIII-DP
Presentation: Frozen Factor VIII Deficient – Depleted Plasma
Preparation/Handling: Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.
Storage and Stability: Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.
Factor VIII (formerly referred to as antihemophilic globulin and Factor VIII:C) is a large glycoprotein (320 kDa) that circulates in plasma at approximately 200 ng/ml. Synthesized in the liver, the majority of Factor VIII is cleaved during expression, resulting in a heterogeneous mixture of partially cleaved forms of FVIII ranging in size from 200-280 kDa. The FVIII is stabilized by association with von Willebrand Factor to form a FVIII-vWF complex required for the normal survival of FVIII in vivo (t1/2 of 8-12 hours).
F.VIII is a pro-cofactor that is activated through limited proteolysis by thrombin. In this process F.VIIIa dissociates from vWF to combine with activated Factor IX, calcium and a phospholipid surface where it is an essential cofactor in the assembly of the Factor X activator complex. Once dissociated from vWF, FVIIIa is susceptible to inactivation by activated Protein C and by non-enzymatic decay.
Hemophilia A is a congenital bleeding disorder resulting from an X-chromosome-linked deficiency of FVIII. The severity of the deficiency generally correlates with the severity of the disease. Some Hemophiliacs (~10%) produce a FVIII protein that is partially or totally inactive. The production of neutralizing antibodies to FVIII also occurs in 5-20% of Hemophiliacs 1-3.
References and Reviews
Lollar P, Fay PJ, Fass DN; Factor VIII and Factor VIIIa. Methods in Enzymology, 222, pg 122, 1993.
Hoyer, LW, Wyshock EG, Colman RW, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 109-133, J.B. Lippincott Co., Philadelphia, 1994.
Pittman DD, Kaufman RJ. Structure-Function Relationships of Factor VIII Elucidated through Recombinant DNA Technology. Thromb. Haemostas. 61:161-165, 1989.
Factor VIII Deficient – Depleted Plasma
FVIII-DP – Factor VIII Deficient Plasma – 1ml or bulk quantities
Description
Factor VIII Deficient – Depleted Plasma
Factor VIII Deficient – Depleted Plasma is manufactured from normal citrated human plasma that has been depleted of Factor VIII by selective affinity immuno-adsorption using antibodies directed towards FVIII.
Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1ml vials to litre quantities. Our Factor VIII deficient – depleted plasma can be used for further manufacturing or research use only applications.
Product Code: FVIII-DP
Presentation: Frozen Factor VIII Deficient – Depleted Plasma
Preparation/Handling: Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.
Storage and Stability: Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.
Certificate of Analysis: available upon request
Description of Factor VIII (FVIII)
Factor VIII (formerly referred to as antihemophilic globulin and Factor VIII:C) is a large glycoprotein (320 kDa) that circulates in plasma at approximately 200 ng/ml. Synthesized in the liver, the majority of Factor VIII is cleaved during expression, resulting in a heterogeneous mixture of partially cleaved forms of FVIII ranging in size from 200-280 kDa. The FVIII is stabilized by association with von Willebrand Factor to form a FVIII-vWF complex required for the normal survival of FVIII in vivo (t1/2 of 8-12 hours).
F.VIII is a pro-cofactor that is activated through limited proteolysis by thrombin. In this process F.VIIIa dissociates from vWF to combine with activated Factor IX, calcium and a phospholipid surface where it is an essential cofactor in the assembly of the Factor X activator complex. Once dissociated from vWF, FVIIIa is susceptible to inactivation by activated Protein C and by non-enzymatic decay.
Hemophilia A is a congenital bleeding disorder resulting from an X-chromosome-linked deficiency of FVIII. The severity of the deficiency generally correlates with the severity of the disease. Some Hemophiliacs (~10%) produce a FVIII protein that is partially or totally inactive. The production of neutralizing antibodies to FVIII also occurs in 5-20% of Hemophiliacs 1-3.
References and Reviews
Related Products:
Factor VIII Paired Antibody Set
F8C-EIA – Factor VIII:C Paired Antibody Set – 4 plate set
Factor VIII Deficient – Depleted Plasma
FVIII-DP – Factor VIII Deficient Plasma – 1ml or bulk quantities
Factor VIII ELISA Kit
FVIII-AG – Complete Factor VIII Antigen ELISA Kit – 1 plate/kit
Factor VIII:C Polyclonal Antibody – Affinity Purified
SAF8C-AP – Sheep anti human Factor VIII:C, affinity purified IgG (0.5 mg vial)
Factor VIII:C Polyclonal Antibody – HRP Conjugated
SAF8C-HRP – Sheep anti human Factor VIII:C, peroxidase conjugated IgG (0.2 mg vial)
Canine Factor VIII Polyclonal Antibody
SAC8C-IG – Sheep anti Canine Factor VIII, purified IgG (5mg vial)
Factor VIII:C Polyclonal Antibody – Affinity Purified – FITC Conjugated
SAF8C-APFTC – Sheep anti human Factor VIII:C, affinity purified, FITC conjugated IgG (0.1 mg vial)
Canine Factor VIII:C Polyclonal Antibody – HRP Conjugated
SAC8C-HRP – Sheep anti-canine Factor VIII:C,peroxidase conjugated IgG (0.2 mg vial)
Factor VIII Inhibitor Plasma
INH8-DP – Frozen Factor VIII Inhibitor Plasma – 1ml and bulk
INH8-LDP – Lyophilized Factor VIII Inhibitor Plasma – 1ml
Factor VIII Polyclonal Antibody
SAF8C-IG – Sheep anti human Factor VIII, purified IgG (10mg vial)
Canine Factor VIII Paired Antibody Set
CFVIII-EIA –Canine Factor VIII Paired Antibody Set – 4 plate set
Factor VIII:C Polyclonal Antibody – Affinity Purified – Biotinylated
SAF8C-APBIO – Sheep anti human Factor VIII:C, affinity purified, Biotinylated IgG (0.1 mg vial)
Frozen Factor VIII Deficient Plasma
FRDP080105 – VisuDep-F Frozen Factor VIII deficient plasma – 5 x 1ml Box (IVD)
FRDP080125 – VisuDep-F Frozen Factor VIII deficient plasma – 25 x 1ml Box (IVD)